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Asthma is a complex disease characterized
by airway inflammation, bronchial hyper-
responsiveness, and airflow obstruction.
Tumor necrosis factor-α (TNF), the deﬁning
member of the TNF family of cytokines, has
been directly implicated in asthmatic airway
inﬂammation and bronchial hyperresponsive-
ness (Babu et al. 2004; Thomas 2001).
Lymphotoxin-α (LTA), also called TNF-β,
shares receptors with TNF. The TNF
[GenBank accession no. X02910 (http://
www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?
val=X02910)] and LTA [GenBank accession
no. X01393 (http://www.ncbi.nlm.nih.gov/
entrez/viewer.fcgi?val=X01393)] genes are
located consecutively in the class III region of
the human major histocompatibility complex
(MHC) on chromosome 6p21, which has
shown evidence of linkage to asthma, atopy,
and related phenotypes in multiple genome-
wide studies (Collaborative Study on the
Genetics of Asthma 1997; Daniels et al.
1996).
Single nucleotide polymorphisms (SNPs)
of both TNF and LTA inﬂuence gene expres-
sion. (Knight et al. 2004; Kroeger et al. 1997;
Messer et al. 1991; Ozaki et al. 2002; Wilson
et al. 1997). In particular, a SNP in the TNF
promoter region (TNF-308) and a SNP
within the first intron of LTA (LTA NcoI)
affect the rate of gene transcription and pro-
tein production (Kroeger et al. 1997; Messer
et al. 1991; Ozaki et al. 2002; Wilson et al.
1997). Several studies have indicated an asso-
ciation of the TNF-308 SNP with asthma
and atopy susceptibility (Albuquerque et al.
1998; Bilolikar et al. 2005; Chagani et al.
1999; Di Somma et al. 2003; Gao et al.
2006; Gupta et al. 2005; Li Kam Wa et al.
1999; Li YF et al. 2006; Moffatt and
Cookson 1997; Sandford et al. 2004; Sharma
et al. 2006; Shin et al. 2004; Wang et al.
2004; Winchester et al. 2000; Witte et al.
2002), although other studies do not (Beghe
et al. 2004; Buckova et al. 2002; El Bahlawan
et al. 2003; Lin et al. 2002; Louis et al. 2000;
Moffatt et al. 1999; Randolph et al. 2005;
Trabetti et al. 1999; Zhu et al. 2000). The
LTA NcoI SNP was reported to be associated
with asthma (Albuquerque et al. 1998;
Bilolikar et al. 2005; Moffatt and Cookson
1997; Sharma et al. 2006); however, most
studies showed no association (Buckova et al.
2002; Cardaba et al. 2001; El Bahlawan et al.
2003; Immervoll et al. 2001; Izakovicova
Holla et al. 2001; Li Kam Wa et al. 1999;
Lin et al. 2002; Migita et al. 2005; Moffatt
et al. 1999; Noguchi et al. 2002; Randolph
et al. 2005; Sandford et al. 2004; Shin et al.
2004; Trabetti et al. 1999; Van Hage-
Hamsten et al. 2002; Wang et al. 2004;
Witte et al. 2002). The TNF-857 and LTA-
753 SNPs in the promoter regions have also
been associated with asthma and atopy
(Migita et al. 2005; Noguchi et al. 2002).
The effects of TNF and LTA SNPs on
asthma and atopy remain unresolved due to
the conﬂicting results across studies.
The etiology of asthma and atopy
involves interactions between genetic suscep-
tibility and exposure to environmental trig-
gers, such as secondhand smoke, ozone,
particulate matter, allergens, and endotoxin
(Tatum and Shapiro 2005). TNF has been
identified as a candidate gene for ozone-
induced airway inflammation and hyperre-
sponsiveness (Kleeberger et al. 1997), and
genetic variation in TNF and LTA has been
associated with respiratory effects of ozone in
humans (Yang et al. 2005). Parental smoking
has been consistently related to childhood
asthma [U.S. Department of Health and
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BACKGROUND: Polymorphisms in the proinflammatory cytokine genes tumor necrosis factor-α
(TNF) and lymphotoxin-α (LTA, also called TNF-β) have been associated with asthma and atopy
in some studies. Parental smoking is a consistent risk factor for childhood asthma. Secondhand
smoke and ozone both stimulate TNF production.
OBJECTIVES: Our goal was to investigate whether genetic variation in TNF and LTA is associated
with asthma and atopy and whether the association is modiﬁed by parental smoking in a Mexican
population with high ozone exposure.
METHODS: We genotyped six tagging single nucleotide polymorphisms (SNPs) in TNF and LTA,
including functional variants, in 596 nuclear families consisting of asthmatics 4–17 years of age and
their parents in Mexico City. Atopy was determined by skin prick tests.
RESULTS: The A allele of the TNF-308 SNP was associated with increased risk of asthma [relative
risk (RR) = 1.54; 95% confidence interval (CI), 1.04–2.28], especially among children of non-
smoking parents (RR = 2.06; 95% CI, 1.19–3.55; p for interaction = 0.09). Similarly, the A allele
of the TNF-238 SNP was associated with increased asthma risk among children of nonsmoking
parents (RR = 2.21; 95% CI, 1.14–4.30; p for interaction = 0.01). LTA SNPs were not associated
with asthma. Haplotype analyses reflected the single SNP findings in magnitude and direction.
TNF and LTA SNPs were not associated with the degree of atopy.
CONCLUSIONS: Our results suggest that genetic variation in TNF may contribute to childhood
asthma and that associations may be modiﬁed by parental smoking.
KEY WORDS: allergy, asthma, atopy, environmental tobacco smoke, genetic predisposition to
disease, lymphotoxin-α (LTA), ozone, secondhand smoke, single nucleotide polymorphism
(SNP), tumor necrosis factor-α( TNF). Environ Health Perspect 115:616–622 (2007).
doi:10.1289/ehp.9740 available via http://dx.doi.org/ [Online 16 January 2007]Human Services (DHHS) 2006] and TNF
may inﬂuence the lung inﬂammatory response
to tobacco smoke (Churg et al. 2003; Park
et al. 2003). Few studies have examined
whether exposure to parental smoking modiﬁes
the relationship between TNF and LTA poly-
morphisms and asthma risk. We used the
case–parent triad design to investigate the asso-
ciation of TNF and LTA polymorphisms and
haplotypes with childhood asthma and atopy
in asthmatic children from Mexico City, an
area with the highest ozone exposure in North
America. We also examined possible effect
modiﬁcation by exposure to parental smoking.
Methods
Study design and subject enrollment. We used
the case–parent triad design (Weinberg et al.
1998; Wilcox et al. 1998). The study popula-
tion included 536 case–parent triads and 60
case–parent pairs with adequate DNA sam-
ples for genotyping of at least one SNP for
the TNF and LTA genes. The cases were chil-
dren 4–17 years of age with asthma diagnosed
by a pediatric allergist at the allergy referral
clinic of a large public pediatric hospital in
central Mexico City (Hospital Infantil de
Mexico Federico Gomez). Children and par-
ents provided blood samples as sources of
DNA. A parent, nearly always the mother,
completed a questionnaire on the child’s
symptoms and risk factors for asthma includ-
ing current parental smoking, parental smok-
ing during the ﬁrst 2 years of the child’s life,
maternal smoking during pregnancy, and
residential history.
We obtained measurements of ambient
ozone from the Mexican government’s air
monitoring stations (http://www.ine.gob.mx/
dgicurg/calaire/tend/concentra.php). Ozone
levels were measured via ultraviolet pho-
tometry (analyzer model 400, Advanced
Pollution Instrumentation, San Diego, CA,
USA). The residence of each child who par-
ticipated in this study was located using a
map, and the closest monitoring station was
assigned to that residence (Romieu et al.
2002). The ozone exposure data were col-
lected for the year before the time of entry
into the study. The parameter we used was
the annual average of the daily maximum 8-
hr averages. We dichotomized this variable at
the median of 67 ppb for stratiﬁed analyses. 
The protocol was reviewed and approved
by the institutional review boards of the
Mexican National Institute of Public Health,
the Hospital Infantil de Mexico Federico
Gomez, and the U.S. National Institute of
Environmental Health Sciences (NIEHS).
Parents provided the written informed con-
sent for the child’s participation. Children
also gave their informed assent.
Clinical evaluation. The diagnosis of
asthma was based on clinical symptoms and
response to treatment by a pediatric allergist
[British Thoracic Society/Scottish Inter-
collegiate Guidelines Network (BTS/SIGN)
2003]. The severity of asthma was rated by a
pediatric allergist for 571 cases according to
symptoms in the Global Initiative on Asthma
schema as mild (intermittent or persistent),
moderate, or severe [National Heart, Lung,
and Blood Institute (NHLBI) 1998]. At a
different point of time, for research purposes,
pulmonary function was measured using
the EasyOne spirometer (ndd Medical
Technologies, Andover, MA, USA) for 446
cases according to American Thoracic Society
(ATS) specifications (ATS 1995). The best
test of three technically acceptable tests was
selected. Spirometric prediction equations
from a Mexico City childhood population
were used to calculate the percent predicted
forced expiratory volume in 1 sec (FEV1)
(Perez-Padilla et al. 2003). Children were
asked to hold asthma medications on the
morning of the test.
Atopy was determined using skin prick
tests. The following battery of 24 aeroallergens
common in Mexico City was used: Aspergillus
fumigatus, Alternaria, Mucor, Blattella german-
ica, Periplaneta americana, Penicillium, cat,
dog, horse, Dermatophagoides (pteronyssinus
and farina), Ambrosia, Artemisa ludoviciana,
Cynodon dactylon, Chenopodium album,
Quercus, Fraxinus, Helianthus, Ligustrum vul-
gare, Lolium perenne, Plantago lanceolata,
Rumex crispus, Schinus molle, Salsola, and
Phleum pratense. Histamine was used as a posi-
tive control and glycerin as a negative control.
Children were considered atopic if the diame-
ter of the skin reaction to at least one allergen
exceeded 4 mm. The test was considered valid
if the reaction to histamine was ≥ 6 mm
according to the grading of skin prick test rec-
ommended by Aas and Belin (1973). Skin test
data on all 24 aeroallergens were available on
545 cases.
SNP selection. We had various data
sources available for selection of tagging SNPs.
These included resequencing data in individu-
als of African and European descent by Seattle
SNPs (http://pga.mbt.washington.edu) and
genotyping data on 10 Mexicans and 38
Mexican-Americans with four grandparents
born in Mexico for cosmopolitan haplotype
tagging SNPs identified by the NIEHS
Environmental Genome Project based on rese-
quencing a representative sample of the U.S.
population (http://egp.gs.washington.edu).
We identiﬁed the common haplotypes using
PHASE (Stephens et al. 2001) and then used
ldSelect (Carlson et al. 2004) to identify tag-
ging SNPs. We also analyzed the genotyping
data from seven Mexicans in SNP500Cancer
(Packer et al. 2004) (http://snp500cancer.
nci.nih.gov). TNF and LTA are small genes
located consecutively in a 6 kb region on
chromosome 6, and linkage disequilibrium in
this region is high. We selected six tagging
SNPs—TNF-1031 (rs1799964), TNF-857
(rs1799724), TNF-308 (rs1800629), TNF-
238 (rs361525), LTA-379 (rs2239704), and
LTA NcoI (rs909253)—to cover the whole
region, including all the common SNPs in the
regulatory and coding regions of the genes
with known functional importance (Fong and
Mark 1995; Knight et al. 2004; Kroeger et al.
1997; Messer et al. 1991; Ozaki et al. 2002;
Wilson et al. 1997) or that had been associated
with asthma in the literature. As expected,
given the increasing documentation of the
portability of tagging SNPs across popula-
tions (Gonzalez-Neira et al. 2006), especially
in the less diverse non-African groups, the
tagging SNPs selected provide excellent cover-
age of common haplotypes in other popula-
tions. For example, the six tagging SNPs we
selected based on the Mexican data would
cover all six common haplotypes (> 5%) in
European and ﬁve of six common haplotypes
in African populations.
Genotyping. We extracted DNA from
peripheral blood lymphocyte using Gentra
Puregene kits (Gentra System, Minneapolis,
MN, USA). We obtained genotypes for
the TNF-1031 and TNF-857 SNPs using
TaqMan SNP Genotyping Assay (Li H et al.
2006). Primers and probes were purchased
from Assay-on-Demand (Applied Biosystems,
Foster City, CA, USA). All PCR ampliﬁcations
were performed using 5′ exonuclease assay on
GeneAmp PCR Systems 9700 (Applied
Biosystems). The ﬂuorescence of PCR prod-
ucts was detected using ABI Prism 7900HT
sequence detection system. The TNF-308,
TNF-238, and LTA NcoI SNPs were geno-
typed using a multiplex PCR and immobilized
probe linear array system (Barcellos et al.
2004), provided by Roche Molecular Systems
(Alameda, CA, USA). The LTA-379 SNP was
genotyped using MGB Eclipse Genotyping
Assay (Belousov et al. 2004). Primers and
Probes were purchased from MGB Eclipse by
Design (Epoch Biosciences, Bothell, WA,
USA). All genotyping assays were done by a
researcher who was blinded to parent or child
status of samples. Sixteen quality control sam-
ples were plated per 384-well plate along with
24 control samples with known genotype. An
additional six blind replicate samples were
included in the analyses. The quality controls
and the blind replicates were 100% concordant
for all genotyping methods. 
Nonparentage was ascertained with a set
of short-tandem repeats (AmpFLSTR Proﬁler
Plus; Applied Biosystems) analyzed using
Pedcheck software (University of Pittsburgh,
Pittsburgh, PA, USA) (O’Connell and Weeks
1998). A total of 596 families had genotyping
data for at least one SNP, and 566 families
had genotyping data for all six SNPs.
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likelihood approach to analyze associations
between asthma and individual SNPs
(Weinberg et al. 1998). The log-linear likeli-
hood-ratio test is a powerful and more ﬂexible
alternative to the transmission disequilibrium
test (TDT) and tests the same null hypothesis
of no within-family relationship between the
variant and the disease (Lake and Laird
2004). Similar to TDT-based methods for
the analysis of case–parent data, such as the
family-based association test (FBAT)
(Horvath et al. 2001), the log-linear model
achieves robustness against genetic population
structure through stratification on the possi-
ble parental mating types (Lake and Laird
2004). The log-linear method has the advan-
tage of providing estimates of the magnitude
of associations rather than simply tests of sig-
nificance (Weinberg et al. 1998). We calcu-
lated relative risks for individual SNPs
without restricting to a speciﬁc genetic model.
The log-linear models of case–parent data are
inherently immune to confounding by demo-
graphic or lifestyle factors such as parental
smoking. However, we examined effect modi-
fication by sex, asthma severity, parental
smoking, and level of ozone exposure. We
calculated tests of interactions for the joint
effects of genotype and current parental
smoking and parental smoking before the
child turned two using the method of
Umbach and Weinberg (2000). All analyses
were performed using SAS version 9.1
(SAS Institute Inc., Cary, NC, USA) and
STATA version 8.0 (StataCorp., College
Station, TX, USA). 
To evaluate whether TNF and LTA poly-
morphisms inﬂuenced the degree of atopy, as
assessed by the number of positive skin tests
out of 24 performed, we used the polytomous
logistic method of Kistner and Weinberg to
estimate the linkage and association between
TNF and LTA polymorphisms and atopy
(Kistner and Weinberg 2004). p-Values were
calculated from likelihood ratio tests. We also
used this method to analyze the relationship
between TNF and LTA SNPs and lung func-
tion, as assessed by percent predicted FEV1.
We used HAPLIN version 2.0 (http://
www.uib.no/smis/gjessing/genetics/
software/haplin) to analyze associations
between asthma and TNF and LTA haplo-
types. HAPLIN is an extension of the log-
linear model from a single locus to loci with
multiple haplotypes with unknown phase
(Gjessing and Lie 2005). The haplotypes of
individuals with unknown phase are con-
structed from the family information when-
ever possible, and the remaining haplotypes
are estimated by using the expectation-
maximization algorithm (Gjessing and Lie
2005). HAPLIN estimates single- and dou-
ble-dose effects of haplotypes rather than sim-
ply tests of significance using maximum
likelihood (Gjessing and Lie 2005). We set a
threshold of 1% for haplotype frequency,
leaving 582 families in the HAPLIN analyses.
We present the p-values computed using
the above methods. To address the potential
issue of multiple comparisons, we calculated
the false discovery rate for each p-value < 0.05
using the method of Storey (Storey and
Tibshirani 2003). The false discovery rate is
the expected proportion of false positives
incurred when a particular test is called signiﬁ-
cant. However, these corrections will be overly
conservative when applied equally to all SNPs.
Our prior prediction of positive findings
would be greatest for SNPs with known func-
tional importance, such as TNF-308, com-
pared with SNPs chosen only as haplotype
tagging SNPs where functional signiﬁcance is
not well characterized. In addition, the false
discovery rate does not take into account the
correlation between SNPs in a gene.
Results
Clinical characteristics of the asthmatic chil-
dren with genotyping data are presented in
Table 1. The mean (± SD) age of cases was
9.0 ± 2.4 years (range 4–17 years). Most had
mild (71.5%) as opposed to moderate or severe
asthma (28.5%). Nearly all cases (98.3%) had
used medication for asthma in the preceding
12 months. Wheezing in the preceding
12 months was reported by 89.8% and chronic
dry cough was reported by 65.4%. For 73.9%
of cases, asthma symptoms had interfered with
daily activities or school attendance in the pre-
ceding 12 months. Among cases with spirome-
try data, the mean FEV1 percent predicted was
96.7 ± 20.6. Atopy was present in 91.9% of
cases. The highest rates of skin test positivity
were seen for dust mite (70.3%) and cockroach
(43.1%). Although only 5.8% of mothers
reported smoking during pregnancy, 32.6% of
cases lived with a smoking parent in early
childhood (before 2 years of age) and 50.4%
were currently exposed to parental smoking.
The minor allele frequency and genotype
frequency distributions of the six tagging
SNPs are shown in Table 2. The TNF-308
and TNF-238 polymorphisms were relatively
rare in our Mexican population (minor allele
frequency = 5% for TNF-308 and 4%
for TNF-238). The frequency distributions
for all mating types for TNF and LTA poly-
morphisms are presented in Supplemental
Table 1 for all families, Supplemental Table 2
for families with smoking parents, and
Supplemental Table 3 for families with non-
smoking parents (Supplemental Material
online at http://www.ehponline.org/docs/
2007/9740/suppl.pdf). Hardy-Weinberg
equilibrium (p > 0.1) was conﬁrmed for all six
tagging SNPs in the parents. Pairwise linkage
disequilibrium coefficients, D, and r 2,
Wu et al.
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Table 1. Demographic and clinical characteristics
of the 596 asthmatic children.
Clinical characteristics Value
Age [years (mean ± SD)] 9.0 ± 2.4
Sex (male) 61.1
Asthma severity (n = 571)
Mild 71.5
Moderate to severe 28.5
Asthma medication in the  98.3
preceding 12 months (n = 590)
FEV1 [percent predicted (mean ± SD)] 96.7 ± 20.6
(n = 446)
Skin test positivity (of 24 aeroallergens) (n = 545)
≥ 1 allergen 91.9
≥ 5 allergens 52.8
Parental smoking (n = 591)
Mother smoked during pregnancy 5.8
In early childhood (< 2 years of age) 32.6
Current smoking parent 50.4
Values are expressed as percent except where noted. 
Table 2. Genotype distributions for LTA and TNF polymorphisms.
No. of cases with  No. of cases with  Minor allele 
Locus Genotype All cases smoking parents nonsmoking parents frequencya
LTA-379 CC 159 85 74 0.48
CA 299 147 148
AA 138 66 71
LTA NcoI AA 251 121 128 0.34
AG 268 141 124
GG 65 32 33
TNF-1031 TT 420 208 208 0.15
TC 146 74 71
CC 18 9 9
TNF-857 CC 316 165 150 0.27
CT 221 106 111
TT 50 21 29
TNF-308 GG 513 268 240 0.05
GA 65 25 40
AA 0 0 0
TNF-238 GG 525 269 252 0.04
GA 50 22 28
AA 3 2 1
See the Supplemental Material (http://www.ehponline.org/docs/2007/9740/suppl.pdf) for the frequency distributions for all
mating types for TNF and LTA polymorphisms for all families and by parental smoking status.
aMinor allele frequency was calculated using parent genotyping data. between LTA and TNF SNPs, calculated
using FBAT (Horvath et al. 2001) are shown
in Supplemental Table 4 in the online
Supplemental Material. There was moderate
linkage disequilibrium between the LTA-379
and LTA NcoI polymorphisms (r2 = 0.50),
and weak linkage disequilibrium between
the LTA-379 and TNF-857 polymorphisms
(r2 = 0.39), the TNF-1031 and TNF-238
polymorphisms (r2 = 0.25), the LTA NcoI
and TNF-857 polymorphisms (r2 = 0.20),
and the LTA-379 and TNF-1031 polymor-
phisms (r2 = 0.16). The r2 values for all other
SNP pairs were < 0.1.
Neither of the two SNPs in LTA was asso-
ciated with asthma (Table 3). For TNF, carry-
ing at least one copy of the TNF-308A allele
was associated with increased asthma risk
[relative risk (RR) = 1.54; 95% confidence
interval (CI), 1.04–2.28; p = 0.031; false
discovery rate = 0.12] relative to homozygotes
for the major G allele (Table 3). Only three
cases were homozygous for the minor allele
for TNF-238 and none for TNF-308, so we
were not able to evaluate the relative risks for
homozygotes. The TNF-238, TNF-857, and
TNF-1031 polymorphisms gave weaker, and
more unstable, evidence of association with
asthma (Table 3). Results for the six tagging
SNPs did not differ appreciably by sex,
asthma severity (mild versus moderate to
severe), or ozone level (data not shown). We
did not observe a clear pattern of associations
between the TNF and LTA SNPs and percent
predicted FEV1 (data not shown).
Because of the consistent association
between parental smoking and childhood
asthma (DHHS 2006) and the involvement
of TNF in cigarette smoke–induced inflam-
mation responses (Churg et al. 2003; Park
et al. 2003), we examined the association of
each LTA and TNF SNP with asthma strati-
fied by exposure to a smoking parent in the
home. Among cases without smoking parents
in the home, the TNF-308A allele and
TNF-238A alleles showed increased risk of
asthma (RR = 2.06; 95% CI, 1.19–3.55; p =
0.0097; false discovery rate = 0.04 for
TNF-308A; RR = 2.21; 95% CI, 1.14–4.30;
p = 0.019; false discovery rate = 0.04 for
TNF-238A) (Table 3). The p-values for inter-
action with living with smoking parents were
0.09 for TNF-308 and 0.01 for TNF-238.
For the other two TNF SNPs, although the
results were not statistically significant, the
increased risk of asthma for carrying two
copies of the minor allele also appeared to be
limited to cases with nonsmoking parents
(RR = 2.36; 95% CI, 0.82–6.78 for
TNF-1031C; RR = 1.32; 95% CI, 0.76–2.29
for TNF-857T). Among cases with smoking
parents in the home, none of the six LTA and
TNF polymorphisms were associated with
asthma (Table 3). 
Haplotype analyses results reflected the
single SNP ﬁndings in magnitude and direc-
tion (Table 4). Among all cases, individuals
carrying one copy of the ht5 (CGTCAG)
haplotype, containing the TNF-308A allele,
exhibited an increased risk of asthma of bor-
derline statistical significance (RR = 1.45;
95% CI, 0.97–2.19). Among cases with non-
smoking parents, carrying one copy of the ht6
(CACCGA) haplotype containing the
TNF-238A allele or one copy of the ht5 hap-
lotype exhibited an increased risk of asthma
(RR = 2.15; 95% CI, 1.21–3.82; p = 0.0082
for ht5; RR = 2.40; 95% CI, 1.18–4.81; p =
0.014 for ht6). The false discovery rate was
0.03 for the ht5 and ht6 findings. Among
cases with smoking parents, LTA and TNF
haplotypes were not associated with asthma
(Table 4).
We also examined the association of LTA
and TNF individual SNPs and haplotypes with
asthma stratified by exposure to a smoking
parent before child turned two because expo-
sure in early childhood has also been consis-
tently associated with childhood asthma risk
(DHHS 2006). The analysis results were
Parental smoking, TNF, and asthma
Environmental Health Perspectives • VOLUME 115 | NUMBER 4 | April 2007 619
Table 3. LTA and TNF polymorphisms in relation to childhood asthma risk among all cases and stratiﬁed by
parental smoking status [RR (95% CI)].
Cases with  Cases with 
Locus Genotype All cases smoking parents nonsmoking parents
LTA-379 CC 1.0 1.0 1.0
CA 1.04 (0.82–1.32) 0.95 (0.68–1.31) 1.11 (0.78–1.57)
AA 0.98 (0.71–1.34) 0.93 (0.59–1.45) 1.02 (0.65–1.62)
LTA NcoI AA 1.0 1.0 1.0
AG 1.00 (0.80–1.24) 1.04 (0.76–1.43) 0.94 (0.68–1.30)
GG 0.89 (0.61–1.29) 1.00 (0.60–1.69) 0.79 (0.46–1.35)
TNF-1031 TT 1.0 1.0 1.0
TC 1.01 (0.78–1.30) 0.89 (0.61–1.30) 1.14 (0.80–1.64)
CC 1.22 (0.64–2.33) 0.87 (0.38–2.00) 2.36 (0.82–6.78)
TNF-857 CC 1.0 1.0 1.0
CT 0.96 (0.77–1.19) 0.88 (0.64–1.20) 0.99 (0.73–1.35)
TT 1.13 (0.75–1.70) 0.93 (0.51–1.71) 1.32 (0.76–2.29)
TNF-308 GG 1.0 1.0 1.0
GA 1.54 (1.04–2.28)* 1.09 (0.61–1.94) 2.06 (1.19–3.55)**
AAa —— —
TNF-238 GG 1.0 1.0 1.0
GA 1.22 (0.81–1.85) 0.81 (0.46–1.42) 2.21 (1.14–4.30)#
AAa —— —
aOnly three cases were homozygous for the minor A allele for TNF-238 and none for TNF-308, so we did not calculate
those relative risks. *p = 0.031; false discovery rate = 0.12. **p = 0.0097; false discovery rate = 0.04; p-value for interaction
= 0.09. #p = 0.019; false discovery rate = 0.04; p-value for interaction = 0.01.
Table 4. TNF and LTA haplotypes in relation to childhood asthma risk among all cases and stratified by
parental smoking status [RR (95% CI)].
Haplotypea Frequency Single copy Double copy
All cases
ht1 (CGTCGG) 0.305 0.94 (0.75–1.18) 0.80 (0.53–1.21)
ht2 (AATTGG) 0.271 0.92 (0.72–1.15)  1.11 (0.73–1.67)
ht3 (AATCGG) 0.208 1.00 (0.79–1.26) 1.00 (0.60–1.66)
ht4 (CACCGG) 0.112 0.87 (0.65–1.16) 1.04 (0.47–2.33)
ht5 (CGTCAG) 0.040 1.45 (0.97–2.19) —b
ht6 (CACCGA) 0.035 1.31 (0.85–2.03) —
ht7 (CATCGG) 0.027 1.03 (0.62–1.73) —
Cases with smoking parents
ht1 (CGTCGG) 0.298 1.18 (0.86–1.63) 1.02 (0.57–1.81)
ht2 (AATTGG) 0.271 0.86 (0.62–1.21) 0.89 (0.49–1.66)
ht3 (AATCGG) 0.198 1.09 (0.78–1.54) 1.30 (0.65–2.63)
ht4 (CACCGG) 0.117 0.88 (0.58–1.31) 0.98 (0.32–3.03)
ht5 (CGTCAG) 0.042 0.90 (0.49–1.67) —
ht6 (CACCGA) 0.047 0.84 (0.46–1.52) —
ht7 (CATCGG) 0.022 1.50 (0.72–3.15) —
Cases with nonsmoking parents
ht1 (CGTCGG) 0.310 0.74 (0.54–1.02) 0.64 (0.36–1.16)
ht2 (AATTGG) 0.274 0.92 (0.66–1.27) 1.29 (0.72–2.22)
ht3 (AATCGG) 0.212 0.94 (0.66–1.31) 0.81 (0.38–1.73)
ht4 (CACCGG) 0.107 0.86 (0.57–1.31) 1.16 (0.37–3.53)
ht5 (CGTCAG) 0.038 2.15 (1.21–3.82)* —
ht6 (CACCGA) 0.022 2.40 (1.18–4.81)** —
ht7 (CATCGG) 0.032 0.71 (0.34–1.49) —
aThe haplotypes formed by LTA-379C > A, LTA NcoIA > G, TNF-1031T > C, TNF-857C > T, TNF-308G > A, and TNF-238G > A
in order. bOnly three cases were homozygous for the ht6 haplotype and none for the ht5 and ht7 haplotypes, so we did not
calculate those relative risks. *p = 0.0082; false discovery rate = 0.03. **p = 0.014; false discovery rate = 0.03.consistent with findings for stratifying by
current exposure to a smoking parent in the
home (data not shown). 
We examined the association between
individual LTA and TNF SNPs and the
degree of atopy to aeroallergens, assessed by
the number of positive skin tests out of a bat-
tery of 24 tests. No significant associations
were detected with the number of positive
skin tests for the six LTA and TNF SNPs
(data not shown).
Discussion
In this case–parent triad study in a Mexico
City population with high lifetime exposure
to ozone, we found that the A allele of the
functionally relevant TNF-308 polymorphism
was signiﬁcantly associated with an increased
risk of childhood asthma, especially among
children with nonsmoking parents. The
TNF-238A allele and the haplotypes contain-
ing the TNF-308A allele or the TNF-238A
allele were associated with an increased child-
hood asthma risk predominantly in children
with nonsmoking parents. 
TNF is a potent proinflammation
cytokine and has been consistently implicated
in asthmatic inflammation and bronchial
hyperresponsiveness in a variety of subcellular,
in vitro, ex vivo, in vivo, and genetic studies
(Thomas 2001). For example, TNF expres-
sion is markedly increased in asthmatic
airways compared with normal airways
(Bradding et al. 1994). TNF appears to have
an important amplifying effect on asthmatic
inﬂammation (Babu et al. 2004) and has also
been shown to induce airway hyperresponsive-
ness in rats and humans (Kips et al. 1992;
Thomas et al. 1995). Therefore, genetic poly-
morphisms that affect gene expression or TNF
activity in the airways might be expected to
inﬂuence asthma risk.
The TNF-308 polymorphism has been fre-
quently studied in asthma and atopy association
studies because it has direct functional effects
on TNF gene regulation. The TNF-308A allele
is a much stronger transcriptional activator than
the more common G allele (Wilson et al. 1997)
and is associated with higher TNF production
(Louis et al. 1998). The TNF-308A allele leads
to high binding afﬁnity of nuclear factors to the
TNF promoter and gives a high level of gene
transcription (Kroeger et al. 1997). Thus,
observations from functional studies suggest
that the TNF-308A allele is of biological signiﬁ-
cance. Despite the known effects of tobacco
smoke on TNF expression and the well-
documented association between parental
smoking and childhood asthma, few studies
have evaluated whether exposure to a smoking
parent modiﬁes effects of genetic variation in
TNF on childhood asthma. In our study, the
association was greater among children without
smoking parents in the home.
We also found an association between the
TNF-238A allele and asthma risk among chil-
dren with nonsmoking parents in the home.
The TNF-238 polymorphism was not in link-
age disequilibrium with the TNF-308 poly-
morphism (r2 < 0.01) in our Mexican
population, although they are only 70 bp
apart from each other within the class III
region of the MHC on chromosome 6p.
There is no strong evidence showing that the
TNF-238 polymorphism has a direct effect
on gene expression, although studies suggest
that this region contains a strong repressor
site (–280 to –172) (Fong and Mark 1995).
However, the TNF-238 polymorphism may
be in linkage disequilibrium with a functional
polymorphism that impacts TNF production,
either within the TNF gene or another gene
within the MHC. 
Because the etiology of asthma involves
numerous environmental triggers, heteroge-
neous exposure to environmental stimuli
among different populations may cause con-
ﬂicting results across studies. The inﬂuence of
genotypes on phenotypes may be different
and even opposite at different levels of expo-
sure (Martinez 2005). Therefore, incorporat-
ing environmental exposures, such as parental
smoking, into association studies is impor-
tant. Parental smoking, a reasonably valid
approach to estimate long-term secondhand
smoke exposure in infants and children, is
one of the most consistent risk factors for
childhood asthma (DHHS 2006).
It is not unexpected to ﬁnd differing asso-
ciations between genetic polymorphisms and
asthma susceptibility based on parental smok-
ing exposure. We previously reported that the
protective effect for the NQO1 Ser allele in
GSTM1-null children was limited to those
with nonsmoking parents (David et al. 2003).
A recent genome-wide linkage study found
different regions of linkage to childhood
asthma by parental smoking exposure (Colilla
et al. 2003). Of note, the chromosome 6p
region, containing the TNF gene, was more
strongly linked to asthma among subjects
who did not live with a smoker during
infancy compared with those who lived with
smokers (Colilla et al. 2003).
A recent study showed that the TNF-308
polymorphism modified the effect of home
exposure to smokers on respiratory illness-
related school absence among children mostly
without asthma (Wenten et al. 2005). Another
study in the same population showed that the
TNF-308A allele was associated with an
increased risk of wheezing, especially among
children living in low ozone communities (Li
YF et al. 2006). In the present study, we
found that TNF polymorphisms and haplo-
types were associated with childhood asthma
susceptibility predominantly among children
who did not live with smoking parents.
Because TNF is a candidate gene for
ozone-induced airway inflammation and
hyperresponsiveness (Kleeberger et al. 1997),
we stratiﬁed on the ozone level. It is not sur-
prising that we did not observe effect modiﬁ-
cation by ozone because our population in
central Mexico City was exposed to high life-
time levels of ozone compared with U.S.
populations. The median level of the annual
average of the daily maximum 8-hr averages
for our population was 67 ppb, with an
interquartile range of only 12 ppb.
A possible explanation for our ﬁnding of
an association of TNF polymorphisms with
asthma predominantly for children without
smoking parents is that the combination of
exposure to secondhand smoke and ozone,
which both increase TNF production, over-
whelms the smaller impact of TNF poly-
morphisms on TNF expression. Indeed,
expression levels of TNF are significantly
increased in mice and humans exposed to
tobacco smoke (Churg et al. 2003; Park et al.
2003). TNF has been identiﬁed as a potential
candidate gene for ozone susceptibility
(Kleeberger et al. 1997; Yang et al. 2005) and
ozone exposure can stimulate TNF secretion
from lung cells (Arsalane et al. 1995). Tobacco
smoke and ozone are both strong oxidants
(Tatum and Shapiro 2005) and potent con-
trollers of TNF production (Arsalane et al.
1995; Churg et al. 2003; Park et al. 2003). In
combination, these environmental triggers
may have synergistic effects and overcome the
smaller effects of TNF polymorphisms.
Conversely, in the absence of secondhand
smoke exposure, the inﬂuence of TNF func-
tional polymorphisms on TNF expression
may be greater, which could explain our ﬁnd-
ing of stronger associations at lower levels of
exposure. Of note, for CD14, a pattern recog-
nition receptor in the endotoxin-induced
immune response, associations between the
CD14-159 polymorphism and asthma and
atopy differ at high versus low levels of endo-
toxin exposure (Martinez 2005).
In summary, we found that TNF poly-
morphisms and haplotypes were associated
with childhood asthma susceptibility, espe-
cially among children without smoking par-
ents. These results suggest that the effects of
genetic variation in TNF may be more appar-
ent at lower levels of exposure to substances
such as secondhand smoke, which strongly
inﬂuence TNF expression.
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